Growth Metrics

Pfizer (PFE) Acquisitions (2009 - 2023)

Pfizer (PFE) reported Acquisitions of $43.4 billion for Q4 2023, up 173520.0% on a QoQ basis from $25.0 million in Q3 2023.

Pfizer (PFE) has 10 years of Acquisitions data on file, last reported at $43.4 billion in Q4 2023.

  • Quarterly Acquisitions changed N/A year-over-year to $43.4 billion in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $43.4 billion (up 594.88% YoY) and the FY2025 annual result came in at $6.9 billion, changed N/A from the prior year.
  • Acquisitions improved to $43.4 billion in Q4 2023 per PFE's latest filing, from $25.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $43.4 billion in Q4 2023 and bottomed at $25.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 8.78 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 109.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 65.00 Mn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 43.41 Bn
Jul 2, 2023 25.00 Mn
Oct 2, 2022 6.23 Bn
Apr 3, 2022 6.23 Bn
Jul 2, 2017 415.00 Mn
Apr 2, 2017 585.00 Mn
Dec 31, 2016 689.00 Mn
Oct 2, 2016 13.06 Bn
Jul 3, 2016 4.51 Bn
Apr 3, 2016 110.00 Mn
Dec 31, 2015 144.00 Mn
Sep 27, 2015 15.64 Bn
Jun 28, 2015 1.00 Mn
Mar 29, 2015 678.00 Mn
Sep 28, 2014 195.00 Mn
Jun 30, 2013 15.00 Mn
Dec 31, 2012 268.00 Mn
Apr 1, 2012 782.00 Mn
Dec 31, 2011 94.00 Mn
Oct 2, 2011 19.00 Mn
Apr 3, 2011 3.17 Bn
Dec 31, 2009 43.12 Bn